Insider Transactions in Q2 2021 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2021
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+6.78%
|
-
|
|
Jun 22
2021
|
Barbara Weber |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+40.0%
|
-
|
|
Jun 22
2021
|
Elizabeth M Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+40.0%
|
-
|
|
Jun 22
2021
|
Eric Thomas Schmidt |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+25.0%
|
-
|
|
Jun 22
2021
|
Flavia Borellini |
BUY
Grant, award, or other acquisition
|
Direct |
7,234
+50.0%
|
-
|
|
Jun 22
2021
|
Neil Exter Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+13.28%
|
-
|
|
Jun 22
2021
|
Vincent A. Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,617
+13.22%
|
-
|
|
Jun 17
2021
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
160
-1.88%
|
$5,440
$34.12 P/Share
|
|
Jun 17
2021
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
1,485
-1.5%
|
$49,005
$33.82 P/Share
|
|
Jun 17
2021
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
464
-1.72%
|
$15,776
$34.13 P/Share
|
|
Jun 17
2021
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
324
-0.13%
|
$11,016
$34.12 P/Share
|
|
Jun 17
2021
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
243
-1.92%
|
$8,262
$34.12 P/Share
|
|
Jun 04
2021
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 04
2021
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
164,996
-100.0%
|
$4,949,880
$30.23 P/Share
|
|
Jun 03
2021
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 03
2021
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
378,117
-69.62%
|
$11,343,510
$30.2 P/Share
|
|
May 26
2021
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
May 26
2021
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,231,204
-69.39%
|
$36,936,120
$30.53 P/Share
|
|
May 25
2021
|
Neil Exter Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
May 25
2021
|
Third Rock Ventures Ii, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
135,000
-7.07%
|
$4,050,000
$30.93 P/Share
|
|
Apr 28
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
100
-0.0%
|
$4,200
$42.5 P/Share
|
|
Apr 27
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
23,326
-0.69%
|
$979,692
$42.65 P/Share
|
|
Apr 26
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
52,984
-1.55%
|
$2,225,328
$42.85 P/Share
|
|
Apr 09
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
24,701
-0.72%
|
$1,062,143
$43.83 P/Share
|
|
Apr 08
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
46,228
-1.32%
|
$2,034,032
$44.8 P/Share
|
|
Apr 07
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
27,953
-0.79%
|
$1,257,885
$45.6 P/Share
|
|
Apr 06
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
39,500
-1.11%
|
$1,896,000
$48.06 P/Share
|
|
Apr 05
2021
|
Peter Svennilson Director |
SELL
Open market or private sale
|
Indirect |
18,215
-0.51%
|
$837,890
$46.65 P/Share
|